Clinical Trial Update: Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 pilot study evaluated antioxidant N-acetylcysteine in patients with early-stage breast cancer around biopsy and prior to surgery; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Stage 0/1 Breast Cancer, Post Biopsy | Phase 1 | Status: COMPLETED